{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:44:23Z","timestamp":1793573063865,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.rdc.2019.07.006","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T19:06:32Z","timestamp":1569524792000},"page":"569-581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Idiopathic Inflammatory Myopathies"],"prefix":"10.1016","volume":"45","author":[{"given":"Ji\u0159\u00ed","family":"Vencovsk\u00fd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Alexanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid E.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rdc.2019.07.006_bib1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","article-title":"Autoantibodies in myositis","volume":"14","author":"McHugh","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2019.07.006_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.autrev.2018.10.004","article-title":"Autoantibodies in idiopathic inflammatory myopathies: clinical associations and laboratory evaluation by mono- and multispecific immunoassays","volume":"18","author":"Damoiseaux","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.rdc.2019.07.006_bib3","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2019.07.006_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10.1016\/j.rdc.2019.07.006_bib5","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","article-title":"Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis","volume":"51","author":"Gono","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.rdc.2019.07.006_bib6","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/art.39753","article-title":"Muscle biopsy findings in combination with myositis-specific autoantibodies aid prediction of outcomes in juvenile dermatomyositis","volume":"68","author":"Deakin","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2019.07.006_bib7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.autrev.2017.05.003","article-title":"Integrated diagnosis project for inflammatory myopathies: an association between autoantibodies and muscle pathology","volume":"16","author":"Suzuki","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.rdc.2019.07.006_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrrheum.2018.42","article-title":"Treatment in myositis","volume":"14","author":"Oddis","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2019.07.006_bib9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/art.38270","article-title":"Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis","volume":"66","author":"Aggarwal","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"27","key":"10.1016\/j.rdc.2019.07.006_bib10","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A\u00a0controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.rdc.2019.07.006_bib11","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMc1506163","article-title":"Intravenous immune globulin for statin-triggered autoimmune myopathy","volume":"373","author":"Mammen","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.rdc.2019.07.006_bib12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/rheumatology\/key366","article-title":"Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinib","volume":"58","author":"Moghadam-Kia","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.rdc.2019.07.006_bib13","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/art.39624","article-title":"Endurance exercise improves molecular pathways of aerobic metabolism in patients with myositis","volume":"68","author":"Munters","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2019.07.006_bib14","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/rheumatology\/40.11.1262","article-title":"Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies","volume":"40","author":"Miller","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.rdc.2019.07.006_bib15","first-page":"603","article-title":"Defining clinical improvement in adult and juvenile myositis","volume":"30","author":"Rider","year":"2003","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2019.07.006_bib16","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/art.20349","article-title":"International consensus on preliminary definitions of improvement in adult and juvenile myositis","volume":"50","author":"Rider","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2019.07.006_bib17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial","volume":"65","author":"Oddis","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2019.07.006_bib18","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/annrheumdis-2017-211400","volume":"76","author":"Aggarwal","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2019.07.006_bib19","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/annrheumdis-2017-211401","volume":"76","author":"Rider","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10019","key":"10.1016\/j.rdc.2019.07.006_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","article-title":"Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial","volume":"387","author":"Ruperto","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.rdc.2019.07.006_bib21","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/rheumatology\/keu442","article-title":"Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids","volume":"54","author":"Ibrahim","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.rdc.2019.07.006_bib22","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/acr.22068","article-title":"Improvement in health and possible reduction in disease activity using endurance exercise in patients with established polymyositis and dermatomyositis: a multicenter randomized controlled trial with a 1-year open extension followup","volume":"65","author":"Alemo Munters","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.rdc.2019.07.006_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-018-0711-4","article-title":"Cardiorespiratory fitness and cardiovascular disease prevention: an update","volume":"20","author":"Al-Mallah","year":"2018","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.rdc.2019.07.006_bib24","series-title":"Textbook of work physiology: physiological bases of exercise","first-page":"354","author":"\u00c5strand","year":"1986"},{"issue":"8","key":"10.1016\/j.rdc.2019.07.006_bib25","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1249\/00005768-199108000-00014","article-title":"Development of a single-stage submaximal treadmill walking test","volume":"23","author":"Ebbeling","year":"1991","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"10.1016\/j.rdc.2019.07.006_bib26","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.apmr.2015.09.023","article-title":"Submaximal exercise-based equations to predict maximal oxygen uptake in older adults: a systematic review","volume":"97","author":"Smith","year":"2016","journal-title":"Arch Phys Med Rehabil"},{"issue":"11","key":"10.1016\/j.rdc.2019.07.006_bib27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMoa011858","article-title":"Exercise capacity and mortality among men referred for exercise testing","volume":"346","author":"Myers","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.rdc.2019.07.006_bib28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3899\/jrheum.161183","article-title":"Muscle strength and muscle endurance during the first year of treatment of polymyositis and dermatomyositis: a prospective study","volume":"45","author":"Alexanderson","year":"2018","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2019.07.006_bib29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/art.21715","article-title":"Functional index-2: validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis","volume":"55","author":"Alexanderson","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2019.07.006_bib30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2133.2009.09521.x","article-title":"Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument","volume":"162","author":"Yassaee","year":"2010","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.rdc.2019.07.006_bib31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/BOR.0000000000000442","article-title":"Cardiovascular involvement in myositis","volume":"29","author":"Diederichsen","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2019.07.006_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00421-002-0681-6","article-title":"Muscular adaptations in response to three different resistance-training regimens: specificity of repetition maximum training zones","volume":"88","author":"Campos","year":"2002","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.rdc.2019.07.006_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","article-title":"Psychophysical bases of perceived exertion","volume":"14","author":"Borg","year":"1982","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.rdc.2019.07.006_bib34","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1249\/MSS.0b013e318213fefb","article-title":"Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise","volume":"43","author":"Ewing Garber","year":"2011","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"10.1016\/j.rdc.2019.07.006_bib35","doi-asserted-by":"crossref","first-page":"e000182","DOI":"10.1136\/lupus-2016-000182","article-title":"The use of rituximab in newly diagnosed patients with systemic lupus erythematosus: long-term steroid saving capacity and clinical effectiveness","volume":"4","author":"Gracia-Tello","year":"2012","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.rdc.2019.07.006_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.10924","article-title":"Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence","volume":"49","author":"Bode","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2019.07.006_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/art.23248","volume":"59","author":"Ruperto","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"Suppl 11","key":"10.1016\/j.rdc.2019.07.006_bib38","first-page":"S118","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X19300614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X19300614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:18:02Z","timestamp":1760181482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X19300614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0889857X19300614"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2019.07.006","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Idiopathic Inflammatory Myopathies","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2019.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}